Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-08
2005-02-08
Powers, Fiona T. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S381000, C514S394000, C514S395000
Reexamination Certificate
active
06852743
ABSTRACT:
There is provided an agent for preventing the recurrence of cerebrovascular disorder and an agent for ameliorating troubles following cerebrovascular disorder and inhibiting the progress thereof which contain a compound having an angiotensin II antagonistic activity, a prodrug thereof or a salts thereof.
REFERENCES:
patent: 5250554 (1993-10-01), Naka et al.
patent: 5332831 (1994-07-01), Dowle et al.
patent: 5519138 (1996-05-01), Ries et al.
patent: 5705517 (1998-01-01), Naka et al.
patent: 5958961 (1999-09-01), Inada et al.
patent: 6248729 (2001-06-01), Coniglio et al.
patent: 20040138278 (2004-07-01), Kueppers et al.
patent: 41 42 366 (1993-06-01), None
patent: 0 425 921 (1991-05-01), None
patent: 0 459 136 (1991-12-01), None
patent: 0 556 789 (1993-08-01), None
patent: 0 881 212 (1998-12-01), None
patent: WO-9411369 (1994-05-01), None
patent: WO-9737688 (1997-10-01), None
patent: 0002543 (2000-01-01), None
patent: 0016773 (2000-03-01), None
Sekine et al., Chemical Abstracts, 127:39817, 1997.*
Nagura et al., Chemical Abstracts, 125:25882, 1996.*
Stier et al., Chemical Abstracts, 119:62704, 1993.*
Juan M. Saavedra, “The Role of Angiotensin II in the Regulation of Cerebrovascular Function in the Rat”, Pharm. Pharmacol. Lett., vol. 3, 1994, pp. 256-259, XP009000718.
J. Schrader et al., “Hypertension and Stroke—Rationale Behind the ACCESS Trial”, Basic Research in Cardiology, vol. 93, No. Suppl. 2, 1998, pp. 69-78, XP001019616.
Masatoshi Fujishima, “Nou Kekkan Shougai no Hasshou, Saihatsu to sono Yobou”, Ishiyaku Shuppan K.K., Igaku no Ayumi, vol. 188, No. 4, Jan. 23, 1999, pp. 217-222 (in Japanese).
Masaya Takahashi et al., “Therapeutic effects of imidapril on cerebral lesions observed by magnetic resonance imaging in malignant stroke-prone spontaneously hypertensive rats”, Journal of Hypertension, 1994, vol. 12, No. 7, pp. 761-768.
Tsuneo Hasegawa, “Noukousoku Kanja no Rehabilitation; Kinou Hyouka to Rehabilitation no Susumekata”, Kabkushiki Kaisha Nippon Rinshousha, CT, MRI Jidai no Nousocchu Gaku; Atarashii Shindan, Chiryou Taikei, vol. 1, Nov. 24, 1993, pp. 505-508 (in Japanese).
Kitayoshi Takahito
Miyamoto Masaomi
Ojima Mami
Takeda Pharmaceutical Company Limited
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Preventives for the recurrence of cerebrovascular failure... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preventives for the recurrence of cerebrovascular failure..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preventives for the recurrence of cerebrovascular failure... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3461895